RSS
25 Aug 2023

Akebia Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Author: admintech | Filed under: Press Release

Akebia to host conference call on August 25, 2023 at 9:00 a.m. ET Expects to resubmit NDA for vadadustat as a treatment for anemia due to CKD in adult patients on dialysis in Q3 2023 Reports Auryxia® (ferric citrate) net product revenue of $42.2 million for Q2 2023 and reaffirms 2023 net…

This entry was posted on Friday, August 25th, 2023 at 7:15 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»